HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 88 filers reported holding HEALTH CATALYST INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,550 | -4.1% | 746 | +18.4% | 0.00% | – |
| Q2 2023 | $7,875 | -33.1% | 630 | -37.5% | 0.00% | – |
| Q1 2023 | $11,763 | -22.9% | 1,008 | -29.8% | 0.00% | – |
| Q4 2022 | $15,265 | -73.2% | 1,436 | -75.4% | 0.00% | – |
| Q3 2022 | $57,000 | -5.0% | 5,833 | +42.6% | 0.00% | – |
| Q2 2022 | $60,000 | -45.9% | 4,091 | -4.2% | 0.00% | – |
| Q1 2022 | $111,000 | -26.5% | 4,270 | +12.2% | 0.00% | – |
| Q4 2021 | $151,000 | -34.1% | 3,807 | -17.0% | 0.00% | – |
| Q3 2021 | $229,000 | -9.5% | 4,588 | +0.8% | 0.00% | – |
| Q2 2021 | $253,000 | +17.7% | 4,552 | -0.8% | 0.00% | – |
| Q1 2021 | $215,000 | +10.8% | 4,589 | +3.2% | 0.00% | – |
| Q4 2020 | $194,000 | +14.1% | 4,445 | -4.3% | 0.00% | – |
| Q3 2020 | $170,000 | +2733.3% | 4,645 | +2410.8% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 185 | +38.1% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 134 | +18.6% | 0.00% | – |
| Q4 2019 | $4,000 | +33.3% | 113 | +6.6% | 0.00% | – |
| Q3 2019 | $3,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,439,614 | $15,303,097 | 13.21% |
| Nepsis Inc. | 982,281 | $10,441,647 | 3.50% |
| Numerai GP LLC | 322,906 | $3,432,491 | 2.34% |
| Prosight Management, LP | 347,724 | $3,696,306 | 2.02% |
| First Light Asset Management, LLC | 1,161,995 | $12,352,007 | 1.15% |
| CVS HEALTH Corp | 32,273 | $343,057 | 0.30% |
| Bullseye Asset Management LLC | 47,031 | $500 | 0.27% |
| Granahan Investment Management | 809,485 | $8,604,826 | 0.26% |
| Rock Springs Capital Management LP | 929,900 | $9,884,837 | 0.24% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,913,400 | 0.20% |